[ad_1] The US Food and Drug Administration (FDA) has approved the use of the perampanel antiepileptic drug (FYCOMPA) CIII as monotherapy and adjunctive therapy in pediatric patients for the treatment of partial …
Read More »[ad_1] The US Food and Drug Administration (FDA) has approved the use of the perampanel antiepileptic drug (FYCOMPA) CIII as monotherapy and adjunctive therapy in pediatric patients for the treatment of partial …
Read More »